Welcome to LookChem.com Sign In|Join Free

CAS

  • or
C22H25NO3 is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1301714-93-1 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1301714-93-1 Structure
  • Basic information

    1. Product Name: C22H25NO3
    2. Synonyms:
    3. CAS NO:1301714-93-1
    4. Molecular Formula:
    5. Molecular Weight: 351.445
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1301714-93-1.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: C22H25NO3(CAS DataBase Reference)
    10. NIST Chemistry Reference: C22H25NO3(1301714-93-1)
    11. EPA Substance Registry System: C22H25NO3(1301714-93-1)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1301714-93-1(Hazardous Substances Data)

1301714-93-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1301714-93-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,0,1,7,1 and 4 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1301714-93:
(9*1)+(8*3)+(7*0)+(6*1)+(5*7)+(4*1)+(3*4)+(2*9)+(1*3)=111
111 % 10 = 1
So 1301714-93-1 is a valid CAS Registry Number.

1301714-93-1Relevant articles and documents

Novel Cinnamyl Hydroxyamides and 2-Aminoanilides as Histone Deacetylase Inhibitors: Apoptotic Induction and Cytodifferentiation Activity

Valente, Sergio,Tardugno, Maria,Conte, Mariarosaria,Cirilli, Roberto,Perrone, Andrea,Ragno, Rino,Simeoni, Silvia,Tramontano, Anna,Massa, Silvio,Nebbioso, Angela,Miceli, Marco,Franci, Gianluigi,Brosch, Gerald,Altucci, Lucia,Mai, Antonello

experimental part, p. 698 - 712 (2012/01/06)

Four novel series of cinnamyl-containing histone deacetylase (HDAC) inhibitors 1-4 are described, containing hydroxamate (1 and 3) or 2-aminoanilide (2 and 4) derivatives. When screened against classI (maize HD1-B and human HDAC1) and classII (maize HD1-A and human HDAC4) HDACs, most hydroxamates and 2-aminoanilides displayed potent and selective inhibition toward classI enzymes. Immunoblotting analyses performed in U937 leukemia cells generally revealed high acetyl-H3 and low acetyl-α-tubulin levels. Exceptions are compounds 3f-i, 3m-o, and 4k, which showed higher tubulin acetylation than SAHA. In U937 cells, cell-cycle blockade in either the G2/M or G1/S phase was observed with 1-4. Five hydroxamates (compounds 1h-l) effected a two- to greater than threefold greater percent apoptosis than SAHA, and in the CD11c cytodifferentiation test some 2-aminoanilides belonging to both series 2 and 4 were more active than MS-275. The highest-scoring derivatives in terms of apoptosis (1k, 1l) or cytodifferentiation (2c, 4n) also showed antiproliferative activity in U937 cells, thus representing valuable tools for study in other cancer contexts.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1301714-93-1